In experimental Escherichia coli-induced pneumonia, Masterson et al. (27) demonstrated that CD362+-selected MSCs decreased pneumonia severity and that their efficacy was at least comparable with that of heterogeneous MSCs. Here, SDC2 is linked to susceptibility to pneumonia measurement.